Overview

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the possibility of an association between changes in neurocognitive function, as measured by a computerised test battery, and the use of two different highly active antiretroviral therapy (HAART) regimens in treatment naïve HIV-1 infected subjects commencing antiretroviral therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Imperial College London
Collaborator:
Boehringer Ingelheim
Treatments:
Atazanavir Sulfate
Nevirapine
Ritonavir